Search research articles
Contact Us
Filters
Showing results (71-80 of 279) with videos related to
Page
of 28
Sort By:
Blood
|
October 15, 1990
Effect of recombinant human granulocyte-macrophage colony-stimulating factor administration on the lymphocyte subsets of patients with refractory aplastic anemia
M Faisal, W Cumberland, R Champlin, et al.
Journal of Clinical Microbiology
|
January 1, 1987
Variability of cell surface hydrophobicity among Pasteurella multocida somatic serotype and Actinobacillus lignieresii strains
K R Darnell, M E Hart, F R Champlin
Current Oncology Reports
|
December 21, 2000
Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimens
R Champlin, van Besien K, S Giralt, et al.
The Cancer Journal From Scientific American
|
February 11, 1998
Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells
K van Besien, K Margolin, R Champlin, et al.
Bone Marrow Transplantation
|
February 1, 1995
Treatment of leukemia relapse after bone marrow transplantation with interferon-alpha and interleukin 2
L Shaffer, S Giralt, R Champlin, et al.
Antimicrobial Agents and Chemotherapy
|
July 1, 1983
Conversion of phospholipids to free fatty acids in response to acquisition of polymyxin resistance in Pseudomonas aeruginosa
F R Champlin, H E Gilleland, R S Conrad
FEMS Microbiology Letters
|
February 1, 2007
Susceptibility of compound 48/80-sensitized Pseudomonas aeruginosa to the hydrophobic biocide triclosan
Matthew L Ellison, Amity L Roberts, Franklin R Champlin
Oncology (Williston Park, N.Y.)
|
June 5, 1999
Reinventing bone marrow transplantation. Nonmyeloablative preparative regimens and induction of graft-vs-malignancy effect
R Champlin, I Khouri, S Komblau, et al.
British Journal of Haematology
|
February 1, 1993
Cyclophosphamide and etoposide therapy with GM-CSF for VAD-resistant multiple myeloma
M A Dimopoulos, K B Delasalle, R Champlin, et al.
Cytotherapy
|
August 6, 2005
Umbilical cord blood-derived cells for tissue repair
M Körbling, S Robinson, Z Estrov, et al.
Page
of 28
Search research articles
Search
Showing results (71-80 of 279) with videos related to
Sort By:
Page
of 28
Blood
|
October 15, 1990
Effect of recombinant human granulocyte-macrophage colony-stimulating factor administration on the lymphocyte subsets of patients with refractory aplastic anemia
M Faisal, W Cumberland, R Champlin, et al.
Journal of Clinical Microbiology
|
January 1, 1987
Variability of cell surface hydrophobicity among Pasteurella multocida somatic serotype and Actinobacillus lignieresii strains
K R Darnell, M E Hart, F R Champlin
Current Oncology Reports
|
December 21, 2000
Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimens
R Champlin, van Besien K, S Giralt, et al.
The Cancer Journal From Scientific American
|
February 11, 1998
Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells
K van Besien, K Margolin, R Champlin, et al.
Bone Marrow Transplantation
|
February 1, 1995
Treatment of leukemia relapse after bone marrow transplantation with interferon-alpha and interleukin 2
L Shaffer, S Giralt, R Champlin, et al.
Antimicrobial Agents and Chemotherapy
|
July 1, 1983
Conversion of phospholipids to free fatty acids in response to acquisition of polymyxin resistance in Pseudomonas aeruginosa
F R Champlin, H E Gilleland, R S Conrad
FEMS Microbiology Letters
|
February 1, 2007
Susceptibility of compound 48/80-sensitized Pseudomonas aeruginosa to the hydrophobic biocide triclosan
Matthew L Ellison, Amity L Roberts, Franklin R Champlin
Oncology (Williston Park, N.Y.)
|
June 5, 1999
Reinventing bone marrow transplantation. Nonmyeloablative preparative regimens and induction of graft-vs-malignancy effect
R Champlin, I Khouri, S Komblau, et al.
British Journal of Haematology
|
February 1, 1993
Cyclophosphamide and etoposide therapy with GM-CSF for VAD-resistant multiple myeloma
M A Dimopoulos, K B Delasalle, R Champlin, et al.
Cytotherapy
|
August 6, 2005
Umbilical cord blood-derived cells for tissue repair
M Körbling, S Robinson, Z Estrov, et al.
Page
of 28